Two new composition of matter patents granted in the US and Europe <li /> Patents provide protection relating to lead compound S-pindol ...
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
Stockhead on MSN1d
Neurizon granted US patent for lead drug to treat motor neurone and other neurodegenerative conditionsA patent has been granted in the US covering the use of Neurizon’s lead drug candidate NUZ-001 in neurodegenerative diseases ...
HotCopper.com on MSN1d
Neurizon snags US patent for NUZ-001 after winning FDA orphan status in 2024Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, ...
Key considerations for patent counsel when evaluating potential conflicts of interest, including identifying conflicts between current and former clients, understanding relevant authority, navigating ...
On January 14, 2025, the United States Court of Appeals for the Federal Circuit issued a precedential decision in Lynk Labs, ...
A PA Local analysis dozen such “XXX Capital of the World” nicknames — past and present — for Pennsylvania municipalities, ...
"Last week the Federal Circuit Court of Appeals in Lynk Labs v. Samsung, decided a prior art issue in one of the thornier ...
Anand Barnabas and Anandan S of De Penning & De Penning explain how businesses with a strong technology and R&D focus can use ...
Nixon Peabody was one of the US’s most active IP recruiters in 2024, while US firms in the UK and Europe also made waves ...
The Federal Circuit recently addressed a deceptively straightforward question: does a published U.S. patent application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback